Susquehanna International Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.71M | Buy |
80,001
+28,535
| +55% | +$1.65M | ﹤0.01% | 3738 |
|
|
2025
Q4 | $2.12M | Buy |
51,466
+39,405
| +327% | +$1.53M | ﹤0.01% | 5543 |
|
|
2025
Q3 | $475K | Sell |
12,061
-18,006
| -60% | -$460K | ﹤0.01% | 9081 |
|
|
2025
Q2 | $560K | Sell |
30,067
-17,311
| -37% | -$325K | ﹤0.01% | 8903 |
|
|
2025
Q1 | $859K | Buy |
47,378
+30,856
| +187% | +$680K | ﹤0.01% | 7637 |
|
|
2024
Q4 | $360K | Buy |
+16,522
| New | +$425K | ﹤0.01% | 9418 |
|
|
2024
Q2 | – | Sell |
-205,487
| Closed | -$6.16M | – | 12248 |
|
|
2024
Q1 | $6.16M | Buy |
205,487
+176,808
| +617% | +$3.84M | ﹤0.01% | 3301 |
|
|
2023
Q4 | $298K | Buy |
+28,679
| New | +$317K | ﹤0.01% | 9856 |
|
|
2023
Q3 | – | Sell |
-6,456
| Closed | -$78.3K | – | 12183 |
|
|
2023
Q2 | $78.3K | Sell |
6,456
-4,888
| -43% | -$55.6K | ﹤0.01% | 11115 |
|
|
2023
Q1 | $144K | Buy |
+11,344
| New | +$126K | ﹤0.01% | 10950 |
|
|
2022
Q3 | – | Sell |
-2,873
| Closed | -$55K | – | 13343 |
|
|
2022
Q2 | $55K | Buy |
+2,873
| New | +$71K | ﹤0.01% | 11926 |
|
|
2022
Q1 | – | Sell |
-652
| Closed | -$46K | – | 13155 |
|
|
2021
Q4 | $46K | Buy |
+652
| New | +$65.5K | ﹤0.01% | 12586 |
|
|
2021
Q3 | – | Sell |
-1,288
| Closed | -$201K | – | 12871 |
|
|
2021
Q2 | $201K | Sell |
1,288
-397
| -24% | -$72.9K | ﹤0.01% | 11589 |
|
|
2021
Q1 | $319K | Buy |
1,685
+775
| +85% | +$130K | ﹤0.01% | 10479 |
|
|
2020
Q4 | $114K | Sell |
910
-289
| -24% | -$32.8K | ﹤0.01% | 10432 |
|
|
2020
Q3 | $130K | Buy |
+1,199
| New | +$142K | ﹤0.01% | 9780 |
|
|
2019
Q4 | – | Sell |
-664
| Closed | -$109K | – | 9863 |
|
|
2019
Q3 | $109K | Buy |
+664
| New | +$126K | ﹤0.01% | 9521 |
|
Other funds holding DNTH
APM
RCM
FFM
VCM
OCA
TCM
